James Millis to Time Factors
This is a "connection" page, showing publications James Millis has written about Time Factors.
Connection Strength
0.327
-
De novo sirolimus and reduced-dose tacrolimus versus standard-dose tacrolimus after liver transplantation: the 2000-2003 phase II prospective randomized trial. Am J Transplant. 2014 Feb; 14(2):356-66.
Score: 0.062
-
A novel tunneling method for long-term peritoneal dialysis. Surg Endosc. 2005 Sep; 19(9):1291; author reply 1292.
Score: 0.035
-
Bioartificial liver support: report of the longest continuous treatment with human hepatocytes. Transplant Proc. 2001 Feb-Mar; 33(1-2):1935.
Score: 0.025
-
Safety of continuous human liver support. Transplant Proc. 2001 Feb-Mar; 33(1-2):1954.
Score: 0.025
-
Biliary complications in living donor liver transplantation. Transplant Proc. 1997 Feb-Mar; 29(1-2):419-20.
Score: 0.019
-
Impact of a liberalized donor acceptance policy on liver transplantation. Transplant Proc. 1997 Feb-Mar; 29(1-2):484.
Score: 0.019
-
Tacrolimus for primary treatment of steroid-resistant hepatic allograft rejection. Transplantation. 1996 May 15; 61(9):1365-9.
Score: 0.018
-
Preservation of beta cell function after pancreatic islet autotransplantation: University of Chicago experience. Am Surg. 2015 Apr; 81(4):421-7.
Score: 0.017
-
Randomized prospective trial of OKT3 for early prophylaxis of rejection after liver transplantation. Transplantation. 1989 Jan; 47(1):82-8.
Score: 0.011
-
Uncharacteristically early fatal intraperitoneal rupture of hepatocellular carcinoma following transarterial chemoembolization. Dig Liver Dis. 2009 Feb; 41(2):175-6.
Score: 0.011
-
Impact of graft type on outcome in pediatric liver transplantation: a report From Studies of Pediatric Liver Transplantation (SPLIT). Ann Surg. 2007 Aug; 246(2):301-10.
Score: 0.010
-
Prospective, randomized trial of the effect of antibody induction in simultaneous pancreas and kidney transplantation: three-year results. Transplantation. 2004 Apr 27; 77(8):1269-75.
Score: 0.008
-
Transplantation of liver grafts from living donors into adults--too much, too soon. N Engl J Med. 2001 May 24; 344(21):1633-7.
Score: 0.006
-
An analysis of hepatic retransplantation in children. Transplantation. 1998 May 15; 65(9):1172-8.
Score: 0.005
-
Tacrolimus therapy for refractory renal allograft rejection: experience with steroid withdrawal. Transplant Proc. 1997 Feb-Mar; 29(1-2):307.
Score: 0.005
-
Retransplantation for failed hepatic allografts in children. Transplant Proc. 1997 Feb-Mar; 29(1-2):442-3.
Score: 0.005
-
Long-term outcome of kidney-pancreas transplant recipients with good graft function at one year. Transplantation. 1996 Aug 27; 62(4):451-6.
Score: 0.005
-
FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation. Clin Transplant. 1996 Aug; 10(4):323-32.
Score: 0.005
-
Role of protocol biopsies in the treatment of refractory renal allograft rejection with FK 506. Transplant Proc. 1996 Apr; 28(2):998-9.
Score: 0.005
-
Late complications in kidney-pancreas transplant recipients. Transplant Proc. 1995 Dec; 27(6):3118.
Score: 0.004
-
Role of liver transplantation in patients with hepatitis B infection. Clin Transplant. 1995 Jun; 9(3 Pt 2):269-76.
Score: 0.004
-
Living-donor liver transplantation at UCLA. Am J Surg. 1995 May; 169(5):529-32.
Score: 0.004
-
Radical resection combined with liver transplantation for foregut tumors. Am Surg. 1993 Dec; 59(12):806-12.
Score: 0.004
-
The role of tumor necrosis factor in allograft rejection. II. Evidence that antibody therapy against tumor necrosis factor-alpha and lymphotoxin enhances cardiac allograft survival in rats. Transplantation. 1990 Aug; 50(2):189-93.
Score: 0.003
-
The role of tumor necrosis factor in allograft rejection. I. Evidence that elevated levels of tumor necrosis factor-alpha predict rejection following orthotopic liver transplantation. Transplantation. 1990 Aug; 50(2):219-25.
Score: 0.003
-
Anti-tumor necrosis factor antibody enhances allograft survival in rats. J Surg Res. 1990 Apr; 48(4):345-8.
Score: 0.003
-
Comparison of UW solution and Euro-Collins solutions for cold preservation of human liver grafts. Transplantation. 1990 Feb; 49(2):284-90.
Score: 0.003
-
Effect of a prior portasystemic shunt on subsequent liver transplantation. Ann Surg. 1989 Jan; 209(1):51-6.
Score: 0.003